Amphotericin B-induced myelopathy.
Two patients with coccidioidal meningitis experienced transient neurologic deficits shortly after receiving intrathecal injections of amphotericin B. Continuation of treatment eventually led to a severe flaccid paraparesis with a thoracic sensory level in one patient, and a partial Brown-Séquard's syndrome in the other. Myelography was normal in both, with no evidence of arachnoiditis. Autopsy findings in the first patient showed a focal area of necrosis in the left half of the spinal cord consistent with the patient's clinical findings during life. The distribution of the lesion corresponded to the area supplied by a central sulcal artery. Amphotericin B may exert a direct toxic effect on the spinal cord or its vascular supply when given intrathecally.
D000666:Amphotericin B / Q000009:adverse effects* / Q000627:therapeutic use; D003048:Coccidiosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D008875:Middle Aged; D009123:Muscle Hypotonia / Q000139:chemically induced; D009192:Myelography; D010243:Paralysis / Q000139:chemically induced; D013116:Spinal Cord / Q000187:drug effects; D013118:Spinal Cord Diseases / Q000139:chemically induced*
D000666:Amphotericin B